Health-related quality of life and prognosis in patients with chronic kidney disease: a 3-year follow-up study

Clinical and Experimental Nephrology

Volumn 18, Issue 5, 2014, Pages 697-703

  Okubo, Reiko ^a   Kai, Hirayasu ^a   Kondo, Masahide ^a   Saito, Chie ^a   Yoh, Keigyou ^a   Morito, Naoki ^a   Usui, Joichi ^a   Yamagata, Kunihiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Chronic kidney disease (CKD); EuroQol (EQ 5D); Health related quality of life (HRQOL); Prognosis; Proteinuria; Quality adjustment weight

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE COURSE; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; PROTEINURIA; QUALITY OF LIFE; JAPAN; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY;

DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; QUALITY OF LIFE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84919335468     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0901-x     Document Type: Article

References (22)

1. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–63.
2. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.
3. Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan as of Dec 31, 2011. Tokyo: Japanese Society for Dialysis Treatment; 2012 (in Japanese).
4. Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30.
5. Finkelstein FO, Wuerth D, Finkelstein SH. Health related quality of life and the CKD patient: challenges for the nephrology community. Kidney Int. 2009;76(9):946–52.
6. Mujais SK, Story K, Brouillette J, et al. Health-related quality of life in CKD Patients: correlates and evolution over time. Clin J Am Soc Nephrol. 2009;4:1293–301.
7. Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis. 2005;45:658–66.
8. Chow FY, Briganti EM, Kerr PG, et al. Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis. 2003;41:596–604.
9. Pagels AA, Söderkvist BK, Medin C, et al. Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment. Health Qual Life Outcomes. 2012;10:71.
10. Team Japanese EuroQol Translation. The development of the Japanese EuroQol instrument. J Health Care Soc. 1997;8:109–23 (in Japanese).
11. Tsuchiya A, Ikeda S, Ikegami N, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11:341–53.
12. Tajima R, Kondo M, Kai H, et al. Measurement of health-related quality of life in patients with chronic kidney disease in Japan with EuroQol (EQ-5D). Clin Exp Nephrol. 2010;14:340–8.
13. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17–28.
14. Hemmelgarn BR, Zhang J, Manns B, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006;69:2155–61.
15. Kelley K, Aricak OT, Light RP, et al. Proteinuria is a determinant of quality of life in diabetic nephropathy: modeling lagged effects with path analysis. Am J Nephrol. 2007;27:488–94.
16. Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR: revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
17. Nakayama M, Sato T, Sato H, et al. Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: Gonryo study. Clin Exp Nephrol. 2010;14:333–9.
18. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evidence, classification, and stratification. Am J Kidney Dis. 2002;39:S1–266.
19. Yamashita T, Yoshida T, Ogawa T, et al. Clinical outcomes in patients with chronic kidney disease: a 5-year retrospective cohort study at a University Hospital in Japan. Clin Exp Nephrol. 2011;15:831–40.
20. Hanratty R, Chonchol M, Miriam Dickinson L, et al. Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrol Dial Transplant. 2010;25:801–7.
21. Gansevoort RT, Matsushita K, van der Velde M, et al. Chronic Kidney Disease Prognosis Consortium: lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80:93–104.
22. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073–81.